Oct 26, 2016 12:04 pm UTC| Business
CENTENNIAL, Colo., Oct. 26, 2016 -- Uranium Resources, Inc. (URI or the Company) (Nasdaq:URRE) (ASX:URI), announced today that its wholly-owned subsidiary, Lithium Holdings Nevada LLC recently completed the staking of...
Oct 26, 2016 12:04 pm UTC| Business
CENTENNIAL, Colo., Oct. 26, 2016 -- Uranium Resources, Inc. (URI or the Company) (Nasdaq:URRE) (ASX:URI), announced today that its wholly-owned subsidiary, Lithium Holdings Nevada LLC recently completed the staking of...
Oritani Financial Corp. Announces Dividend and Quarterly Results
Oct 26, 2016 12:04 pm UTC| Business
TOWNSHIP OF WASHINGTON, N.J., Oct. 26, 2016 -- Oritani Financial Corp. (the “Company” or “Oritani”) (NASDAQ:ORIT), the holding company for Oritani Bank (the “Bank”), reported net income of $10.6 million, or $0.25 per...
Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016
Oct 26, 2016 12:04 pm UTC| Business
Webcast on Thursday, November 17, 1:00 p.m. at www.paratekpharma.com BOSTON, Oct. 26, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of...
Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016
Oct 26, 2016 12:04 pm UTC| Business
Webcast on Thursday, November 17, 1:00 p.m. at www.paratekpharma.com BOSTON, Oct. 26, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of...
Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016
Oct 26, 2016 12:04 pm UTC| Business
Webcast on Thursday, November 17, 1:00 p.m. at www.paratekpharma.com BOSTON, Oct. 26, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of...
Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016
Oct 26, 2016 12:04 pm UTC| Business
Webcast on Thursday, November 17, 1:00 p.m. at www.paratekpharma.com BOSTON, Oct. 26, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of...